Mark E. Issa
Impact in
- Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity
-
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Kerry B. Goralski (5 shared papers)Christopher J. Sinal (2 shared papers)Matthew C. Ernst (2 shared papers)Muriel Cuendet (9 shared papers)Wim Vanden Berghe (1 shared paper)Claudina Pérez-Novo (1 shared paper)Chandra Sekhar Chirumamilla (1 shared paper)Sarah Berndt (2 shared papers)
- Journals
- Planta Medica (2 papers)Clinical Epigenetics (1 paper)Endocrinology (1 paper)Anti-Cancer Drugs (1 paper)MedChemComm (1 paper)
- Partner nations
- CanadaSwitzerlandUnited States
In The Last Decade
Mark E. Issa
18 papers receiving 526 citations
Peers
Comparison fields: 5 of 79
- Endocrine and Autonomic Systems 55
- Epidemiology 189
- Complementary and alternative medicine 40
- Physiology 115
- Pharmacology 60
Countries citing papers authored by Mark E. Issa
This map shows the geographic impact of Mark E. Issa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Issa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Issa more than expected).
Fields of papers citing papers by Mark E. Issa
This network shows the impact of papers produced by Mark E. Issa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Issa. The network helps show where Mark E. Issa may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Issa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 217 | |
| 2 | 2017 | 65 | |
| 3 | 2012 | 34 | |
| 4 | 2015 | 32 | |
| 5 | 2013 | 30 | |
| 6 | 2016 | 30 | |
| 7 | 2017 | 22 | |
| 8 | 2017 | 19 | |
| 9 | 2016 | 18 | |
| 10 | 2021 | 13 | |
| 11 | 2018 | 13 | |
| 12 | 2024 | 10 | |
| 13 | 2017 | 10 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 4 | |
| 16 | 2017 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2008 | 1 |
About Mark E. Issa
Mark E. Issa is a scholar working on Molecular Biology, Oncology, Immunology, Pathology and Forensic Medicine and Complementary and alternative medicine, having authored 18 papers that have together received 532 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (4 papers), Phytochemicals and Medicinal Plants (3 papers), Immune Cell Function and Interaction (3 papers), Cancer Mechanisms and Therapy (3 papers), Immune cells in cancer (3 papers), Apelin-related biomedical research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Andrographolide Research and Applications (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (55 citations), Epidemiology (189 citations), Complementary and alternative medicine (40 citations), Physiology (115 citations) and Pharmacology (60 citations). Mark E. Issa has collaborated with scholars based in Canada, Switzerland and United States. Frequent co-authors include Kerry B. Goralski, Christopher J. Sinal, Matthew C. Ernst, Muriel Cuendet, Wim Vanden Berghe, Claudina Pérez-Novo, Chandra Sekhar Chirumamilla, Sarah Berndt, Gilles Carpentier and A. A. Leslie Gunatilaka. Their work appears in journals such as Planta Medica, Clinical Epigenetics, Endocrinology, Anti-Cancer Drugs and MedChemComm.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.